IDEXX Laboratories Analyst Ratings
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520
IDEXX Laboratories Analyst Ratings
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
IDEXX Laboratories Analyst Ratings
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $655
IDEXX Laboratories Analyst Ratings
Piper Sandler Downgrades Idexx to Neutral, Cites Macro Headwinds
IDEXX Laboratories Analyst Ratings
Goldman Sachs Maintains Buy on IDEXX Laboratories, Raises Price Target to $650
IDEXX Laboratories Analyst Ratings
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
IDEXX Laboratories Analyst Ratings
Goldman Sachs Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $550
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592